Table 1. Gender and age of melanoma cases and controls from GWAS.
| Status | n (%) | Male (%) | Age ≤ 30 yr | Age 30–45 | Age 45–60 | Age > 60 | |
|---|---|---|---|---|---|---|---|
| 23andMe (Stage 1) (n = 291,389) | Cases | 4,824 (1.66) | 2587 (53.6) | 99 (2) | 476 (9.9) | 1,203 (24.9) | 3,056 (63.3) |
| Controls | 286,565 (98.3) | 154,517 (53.9) | 40,028 (13.9) | 8,4188 (29.3) | 7,8037 (27.2) | 8,4312 (29.4) | |
| MD Anderson (Stage 2) (n = 2,830) | Cases | 1,804 (63.7) | 1,060 (58.8) | 142 (7.9) | 441 (24.5) | 684 (37.9) | 536 (29.7) |
| Controls | 1,026 (36.3) | 613 (59.8) | 69 (6.7) | 231 (22.5) | 486 (47.4) | 240 (23.4) | |
| Combined analysis (n = 294,219) | Cases | 6,628 (2.25) | 3677 (2.3) | 241 (3.6) | 9,171 (13.8) | 1,887 (28.4) | 3,592 (54.2) |
| Controls | 287,591 (97.7) | 155,130 (97.7) | 40,097 (13.9) | 84,419 (29.3) | 78,523 (27.3) | 84,552 (29.4) |
Counts and percentages for cases and controls (n (%)) are listed above, stratified by stage of GWAS. We also report number and percentage of male subjects, subjects with age < 30 years, subjects with age 30–45 years, subjects with age 45–60 years, and subjects with age > 60 years.